Auto Amazon Links: No products found.
During an interview on BBC Breakfast, Goodburn made an urgent appeal for increased funding and attention toward brain cancer research and patient care. He emphasized the need for clinical trials currently conducted in other countries to be introduced and made accessible within the UK healthcare system. Highlighting the severity of the situation, he said, “Please establish a national brain cancer lead and give us a chance to fight for our lives because the things that patients are going through out there are unbelievable and so unjust.”
Goodburn expressed deep frustration over the disparity in trial availability, pointing out, “There are clinical trials around the world, in the US, in Australia, in China, that could change lives. We are not seeing them in the UK and it is unfair and unjust.” He went on to plead for greater investment, stating, “Please invest and make the difference. I’m on my knees begging for – not just my own life – but for those of my best friends and those that are affected and the families around the country.” His message was clear: the current state of brain cancer care and research is intolerable and must be transformed.
Ahead of a significant meeting, Goodburn described the event as a potential “unique opportunity for change,” criticizing the existing system for its risk-averse nature amid a crisis where lives are at stake. “We cannot accept the status quo in the system, we cannot be risk-averse. People are dying,” he asserted. He also shared how his advocacy efforts have opened channels of communication at the highest government levels regarding the injustices brain tumour patients face, hoping these discussions will lead to meaningful reforms. “But I hope I can also inspire people on an individual level,” he added.
The charity Brain Tumour Research highlighted that brain cancer remains the leading cause of cancer deaths among people under 40 in the UK. They noted that over 75% of the national investment in brain tumour research comes from charitable organizations, with government funding responsible for just a quarter. Earlier in the year, the Rare Cancers Bill, championed by Edinburgh South West MP Scott Arthur, became law with the goal of encouraging research into rare cancers, defined as those afflicting fewer than 1 in 2,000 individuals. While Goodburn praised the legislation, he argued that having a dedicated brain cancer lead would provide far greater focus on research and clinical trials specific to this disease. Arthur echoed the importance of the bill but expressed optimism that Goodburn’s recent meeting could trigger additional progress: “There is real opportunity in the sector to dismantle the barriers to research that charities, clinicians, and researchers have known about for decades.” He also praised Goodburn as “a fantastic advocate for the brain tumour community” and expressed hope that his meeting with the prime minister would mark a turning point toward tangible advancements
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found.